Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.
about
Progress and problems with the use of suicide genes for targeted cancer therapyUtilization of Rad51C promoter for transcriptional targeting of cancer cells.Regulation of Rad51 promoter.Suberoylanilide hydroxamic acid induces hypersensitivity to radiation therapy in acute myelogenous leukemia cells expressing constitutively active FLT3 mutants.RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells.Use of a Novel Integrase-Deficient Lentivirus for Targeted Anti-Cancer Therapy With Survivin Promoter-Driven Diphtheria Toxin ACritical Length of PEG Grafts on lPEI/DNA Nanoparticles for Efficient in Vivo Delivery.Chinese Herbal Mixture, Tien-Hsien Liquid, Induces G2/M Cycle Arrest and Radiosensitivity in MCF-7 Human Breast Cancer Cells through Mechanisms Involving DNMT1 and Rad51 Downregulation.A nanoparticle formulation that selectively transfects metastatic tumors in miceIntraperitoneal delivery of nanoparticles for cancer gene therapy.Targeting homologous recombination-mediated DNA repair in cancer.A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment.Enzyme/Prodrug Systems for Cancer Gene Therapy.Network Meta-Analysis on the Effects of DNA Damage Response-Related Gene Mutations on Overall Survival of Breast Cancer Based on TCGA Database.Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.Inhibition of RAD51 by siRNA and Resveratrol Sensitizes Cancer Stem Cells Derived from HeLa Cell Cultures to Apoptosis.Use of the XRCC2 promoter for in vivo cancer diagnosis and therapy.Promoter-Operating Targeted Expression of Gene Therapy in Cancer: Current Stage and Prospect.
P2860
Q28262370-39C95F11-9DBB-4FAD-AC2C-19085C8B494AQ33688410-1BEC66AD-4CAF-4288-869D-E171C00CB9B1Q33952859-50EAC4FE-D017-455A-9183-3538B1ACE326Q35075792-D9F8DE87-F95D-4310-9728-9A1028DD1E39Q35237084-CAB5DE94-DB62-41A7-8131-3B6A9C414D2FQ36194681-9F665FB6-84B3-4852-A55E-31259A87AFFCQ36793350-782DE1F6-0D80-495D-A22B-5FCE0D45F0ACQ37147428-D9F94F0F-27F7-4ECF-A737-31D7A842F986Q37157373-94505010-6676-4BC7-BE82-FDDED1C84F03Q38068493-3213778A-792B-4F43-B8D3-B6786F6EF6CFQ38184667-08C2D520-093D-40E1-9AFA-FBE812633329Q38872621-BDC1E7ED-2E04-4B9A-9603-A6D73350F2F2Q39064497-0D71B462-DE3B-49B6-8940-01BB93E251E3Q48131904-DF065CAD-A371-4C57-816E-24A909DEA3E9Q51154816-EE09561D-FDE5-4AAF-BA32-B6EFCE9647FFQ52571383-DC774DB1-4356-4321-8080-1783EDF427F1Q52651261-803EE9CC-A69A-45FC-857D-32D54529109EQ55239952-69E94C8B-4B80-49BB-941E-FEE23EF84BEF
P2860
Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Rad51 promoter-targeted gene t ...... ation and treatment of cancer.
@ast
Rad51 promoter-targeted gene t ...... ation and treatment of cancer.
@en
type
label
Rad51 promoter-targeted gene t ...... ation and treatment of cancer.
@ast
Rad51 promoter-targeted gene t ...... ation and treatment of cancer.
@en
prefLabel
Rad51 promoter-targeted gene t ...... ation and treatment of cancer.
@ast
Rad51 promoter-targeted gene t ...... ation and treatment of cancer.
@en
P2093
P2860
P356
P1433
P1476
Rad51 promoter-targeted gene t ...... ation and treatment of cancer.
@en
P2093
Andrei Seluanov
Christopher M Hine
Vera Gorbunova
P2860
P304
P356
10.1038/MT.2011.215
P577
2011-10-18T00:00:00Z